For more than two decades, the biomedical company Pfizer has been working in the research and development of treatments to respond to the unmet medical needs of people living with rare diseases.

You can learn more about it here:

https://www.pfizer.es/noticia/pfizer_mendelian_presentan_una_plataforma_tecnologica_apoyar_profesionales_sanitarios_investigacion_diagnostico_enfermedades_raras.html


If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like A Day In The Life Of...Hadley Mahon Speaker Series - Niemann-Pick Disease Type C UK’s largest ever NHS rare disease diagnosis programme launched by Mendelian and Modality NHS Partnership Mendelian receives over €570k for its rare disease diagnostics by Innovate UK